- Investing Ideas
- Australian Pharmaceuticals & Biotech Nano Cap Stocks
Australian Pharmaceuticals & Biotech Nano Cap Stocks
Results
6
Stocks with a market cap under US$50M.
6 companies
Little Green Pharma
Market Cap: AU$58.0m
Produces and sells cannabis-based medicinal products across Australia and Europe.
LGP
AU$0.07
7D
-2.8%
1Y
-44.0%
Botanix Pharmaceuticals
Market Cap: AU$54.7m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.02
7D
-9.1%
1Y
-86.7%
Medical Developments International
Market Cap: AU$53.5m
Provides emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.47
7D
4.4%
1Y
-23.4%
Radiopharm Theranostics
Market Cap: AU$43.4m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.01
7D
-9.1%
1Y
-63.0%
Trajan Group Holdings
Market Cap: AU$27.5m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.18
7D
-5.3%
1Y
-80.6%
Vitura Health
Market Cap: AU$16.6m
Engages in the sale and distribution of medicinal cannabis products in Australia.
VIT
AU$0.025
7D
4.2%
1Y
-63.2%